Health Care & Life Sciences » Pharmaceuticals | Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals & Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
71,716.80
58,615.40
131,715.10
134,543.80
123,600.00
231,285
Cost of Goods Sold (COGS) incl. D&A
59,147.70
51,345.60
121,249.00
101,838.00
107,967.00
212,499
Gross Income
12,569.20
7,269.80
10,466.10
32,705.80
15,633.00
18,786
SG&A Expense
5,125.60
2,439.60
4,409.30
9,345.40
9,253.00
12,212
EBIT
7,443.60
4,830.20
6,056.80
23,360.40
6,380.00
6,574
Non Operating Income/Expense
541.00
4,589.10
5,051.40
1,110.80
1,007.00
1,012
Interest Expense
1,536.20
2,094.60
1,519.20
1,635.80
1,506.00
1,603
Pretax Income
6,505.80
7,354.50
9,807.10
23,104.00
5,882.00
5,983
Income Tax
1,339.50
1,482.80
1,980.90
5,162.20
1,175.00
1,160
Consolidated Net Income
5,166.40
5,871.70
7,826.30
17,941.70
4,707.00
4,823
Net Income
5,166.40
5,871.70
7,826.30
17,941.70
4,707.00
4,823
Net Income After Extraordinaries
5,166.40
5,871.70
7,826.30
17,941.70
4,707.00
4,823
Net Income Available to Common
5,166.40
5,871.70
7,826.30
17,941.70
4,707.00
4,823
EPS (Basic)
0.32
0.36
0.48
1.10
0.29
0.30
Basic Shares Outstanding
16,273.80
16,273.80
16,273.80
16,273.80
-
-
EPS (Diluted)
0.32
0.36
0.48
1.10
-
-
Diluted Shares Outstanding
16,273.80
16,273.80
16,273.80
16,273.80
-
-
EBITDA
9,666.70
7,336.90
8,705.40
26,202.80
9,343.00
10,225
Non-Operating Interest Income
57.40
29.70
218.20
268.60
-
-

About Biofil Chemicals & Pharmaceuticals

View Profile
Address
11/12, Sector E, Sanwer Road
Indore Madhya Pradesh 452015
India
Employees -
Website http://www.biofilgroup.net
Updated 07/08/2019
Biofil Chemicals & Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical products. The company products include basic drugs and chemicals, and plastic dripper and caps. It operates through the following segments: Pharmaceuticals, Chemicals, and Plastic.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.